Thought Leadership
Insulin Under the BPCIA: Opportunities and Obstacles
April 22, 2020
Ted Mathias and Stacie Ropka, PhD
Biosimilar Development

Axinn partners Ted Mathias and Stacie Ropka authored the Biosimilar Development article, "Insulin Under the BPCIA: Opportunities and Obstacles."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.